BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 33775567)

  • 1. Prediction of patient-specific quality assurance for volumetric modulated arc therapy using radiomics-based machine learning with dose distribution.
    Ishizaka N; Kinoshita T; Sakai M; Tanabe S; Nakano H; Tanabe S; Nakamura S; Mayumi K; Akamatsu S; Nishikata T; Takizawa T; Yamada T; Sakai H; Kaidu M; Sasamoto R; Ishikawa H; Utsunomiya S
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14215. PubMed ID: 37987544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating plan complexity into the statistical process control of volumetric modulated arc therapy pre-treatment verifications.
    Russo S; Saez J; Esposito M; Bruschi A; Ghirelli A; Pini S; Scoccianti S; Hernandez V
    Med Phys; 2024 Apr; ():. PubMed ID: 38630979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting treatment plan complexity by applying a novel commercial tool.
    Scaggion A; Fusella M; Agnello G; Bettinelli A; Pivato N; Roggio A; Rossato MA; Sepulcri M; Paiusco M
    J Appl Clin Med Phys; 2020 Aug; 21(8):27-34. PubMed ID: 32436656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-institutional generalizability of a plan complexity machine learning model for predicting pre-treatment quality assurance results in radiotherapy.
    Claessens M; De Kerf G; Vanreusel V; Mollaert I; Hernandez V; Saez J; Jornet N; Verellen D
    Phys Imaging Radiat Oncol; 2024 Jan; 29():100525. PubMed ID: 38204910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TPS integrated machine learning tool for predicting patient-specific quality assurance outcomes in volumetric-modulated arc therapy.
    Noblet C; Maunet M; Duthy M; Coste F; Moreau M
    Phys Med; 2024 Feb; 118():103208. PubMed ID: 38211462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement Using Planomics Features on Prediction and Classification of Patient-Specific Quality Assurance Using Head and Neck Volumetric Modulated Arc Therapy Plan.
    Li B; Chen J; Guo W; Mao R; Zheng X; Cheng X; Cui T; Lou Z; Wang T; Li D; Tao H; Lei H; Ge H
    Front Neurosci; 2021; 15():744296. PubMed ID: 34658779
    [No Abstract]   [Full Text] [Related]  

  • 7. Knowledge-based radiation treatment planning: A data-driven method survey.
    Momin S; Fu Y; Lei Y; Roper J; Bradley JD; Curran WJ; Liu T; Yang X
    J Appl Clin Med Phys; 2021 Aug; 22(8):16-44. PubMed ID: 34231970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different optimization strategies on the compatibility between planned and delivered doses during radiation therapy of cervical cancer.
    Jodda A; Piotrowski T; Kruszyna-Mochalska M; Malicki J
    Rep Pract Oncol Radiother; 2020; 25(3):412-421. PubMed ID: 32372881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural Network Model Based on Branch Architecture for the Quality Assurance of Volumetric Modulated Arc Therapy.
    Xie L; Zhang L; Hu T; Li G; Yi Z
    Bioengineering (Basel); 2024 Apr; 11(4):. PubMed ID: 38671783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Peer Review of Palliative Radiation Plans at a Canadian Tertiary Care Cancer Center.
    Gulstene S; Mutsaers A; O'Neil M; Warner A; Rodrigues G
    Cureus; 2024 Apr; 16(4):e57839. PubMed ID: 38721176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the deep learning-based gamma passing rate prediction system for 1.5 T magnetic resonance-guided linear accelerator.
    Tozuka R; Kadoya N; Arai K; Sato K; Jingu K
    Radiol Phys Technol; 2024 Apr; ():. PubMed ID: 38687457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge-based model building for treatment planning for prostate cancer using commercial treatment planning quality assurance software tools.
    Masumoto N; Sasaki M; Nakaguchi Y; Kamomae T; Kanazawa Y; Ikushima H
    Radiol Phys Technol; 2024 Mar; 17(1):337-345. PubMed ID: 37938420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study.
    Geng H; Liao Z; Nguyen QN; Berman AT; Robinson C; Wu A; Nichols RC; Willers H; Mohammed N; Mohindra P; Xiao Y
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative risk analysis of treatment plans for patients with tumor by mining historical similar patients from electronic health records using federated learning.
    Liu Y; Bi D
    Risk Anal; 2023 Dec; 43(12):2422-2449. PubMed ID: 36906293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the prediction of gamma passing rate in dosimetric verification of intensity-modulated radiotherapy using machine learning models based on plan complexity.
    Bin S; Zhang J; Shen L; Zhang J; Wang Q
    Front Oncol; 2023; 13():1094927. PubMed ID: 37546404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the dataset quality in gamma passing rate predictions using machine learning methods.
    Quintero P; Benoit D; Cheng Y; Moore C; Beavis A
    Br J Radiol; 2023 Jul; 96(1147):20220302. PubMed ID: 37129359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance-based optimization (QAO): Towards improving patient-specific quality assurance in volumetric modulated arc therapy plans using machine learning.
    Wall PDH; Fontenot JD
    Phys Med; 2021 Jul; 87():136-143. PubMed ID: 33775567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of complexity and deliverability of prostate cancer treatment plans designed with a knowledge-based VMAT planning technique.
    Wall PDH; Fontenot JD
    J Appl Clin Med Phys; 2020 Jan; 21(1):69-77. PubMed ID: 31816175
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.